Demonstrating Safety and Effective Delivery of Daily Oral Pre-exposure Prophylaxis (PrEP) for Sex Workers in India

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

1,325

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

April 30, 2018

Study Completion Date

June 30, 2018

Conditions
HIV Infection
Interventions
DRUG

Truvada

The demonstration project will use a prospective cohort design, enrolling individuals and following them up at multiple intervals over the course of 16 months. Study participants will be asked to take one tablet of Truvada daily, as HIV Pre-Exposure Prophylaxis, over this period. They will be asked to attend 7 regular visits at the project sites over the course of the project. In between visits, they will receive peer educator home visits every other day, as part of regular DMSC (Kolkata) and Ashodaya (Mysore/Mandya) outreach prevention activities. We plan to enroll 2000 female sex workers equally split between the two sites.

Trial Locations (2)

Unknown

Ashodaya Samithi clinic, Mysore

DMSC Clinic, Kolkata

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

World Health Organization

OTHER

collaborator

DMSC

UNKNOWN

collaborator

Ashodaya Samithi

UNKNOWN

lead

University of Manitoba

OTHER